Template:Further points for assessing the study: Difference between revisions
Appearance
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
<noinclude> | <noinclude> | ||
{{#template_params:Samples sufficiently large (property=Samples sufficiently large)| power analysis performed (property=power analysis performed)| reasons given for samples (property=reasons given for samples)| Ethnicity mentioned (property=Ethnicity mentioned)| Possibility of attention effects (property=Possibility of attention effects)| Possibility of placebo effects (property=Possibility of placebo effects)| Other reasons (property=Other reasons)| Testing for normal distribution (property=Testing for normal distribution)| Correct application of statistical (property=Correct application of statistical)| Correction for multiple testing (property=Correction for multiple testing)| Measurement of compliance (property=Measurement of compliance)| Blinding reliable (property=Blinding reliable)| Check whether blinding was successful (property=Check whether blinding was successful)| Consistent reporting in numbers (property=Consistent reporting in numbers)| Sufficient washout period (property=Sufficient washout period)| Tested for carry-over (property=Tested for carry-over)| Were sequence effects tested (property=Were sequence effects tested)| Comprehensive and coherent reporting (property=Comprehensive and coherent reporting)| Were side effects systematically recorded (property=Were side effects systematically recorded)| Effect sizes reported (property=Effect sizes reported)| Side effects taken into account in the interpretation of the results (property=Side effects taken into account in the interpretation of the results)| mono- or multicentric (property=mono- or multicentric)| Ethics / CoI / Funding (property=Ethics / CoI / Funding)}} | {{#template_params:Samples sufficiently large (property=Samples sufficiently large)| power analysis performed (property=power analysis performed)| reasons given for samples (property=reasons given for samples)| Ethnicity mentioned (property=Ethnicity mentioned)| Possibility of attention effects (property=Possibility of attention effects)| Possibility of placebo effects (property=Possibility of placebo effects)| Other reasons (property=Other reasons)| Testing for normal distribution (property=Testing for normal distribution)| Correct application of statistical (property=Correct application of statistical)| Correction for multiple testing (property=Correction for multiple testing)| Measurement of compliance (property=Measurement of compliance)| Blinding reliable (property=Blinding reliable)| Check whether blinding was successful (property=Check whether blinding was successful)| Consistent reporting in numbers (property=Consistent reporting in numbers)| Sufficient washout period (property=Sufficient washout period)| Tested for carry-over (property=Tested for carry-over)| Were sequence effects tested (property=Were sequence effects tested)| Comprehensive and coherent reporting (property=Comprehensive and coherent reporting)| Were side effects systematically recorded (property=Were side effects systematically recorded)| Effect sizes reported (property=Effect sizes reported)| Side effects taken into account in the interpretation of the results (property=Side effects taken into account in the interpretation of the results)| mono- or multicentric (property=mono- or multicentric)| Ethics / CoI / Funding (property=Ethics / CoI / Funding)}} | ||
</noinclude><includeonly>{| class="wikitable" style="width:75%;" | </noinclude><includeonly> | ||
==Sample== | |||
{| class="wikitable" style="width:75%;" | |||
|- | |- | ||
! width= | ! width=50% style="text-align:left;" | Power analysis performed | ||
| [[ | | style="text-align:center;" | [[power analysis performed::{{{power analysis performed|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | | ! style="text-align:left; text-indent:3em;" | - Sample size corresponds to power analysis | ||
| [[power analysis | | style="text-align:center;" | [[Sample size corresponds to power analysis::{{{Sample size corresponds to power analysis|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | Reasons | ! style="text-align:left; text-indent:3em;" | - Reasons for insufficient sample size based on power analysis | ||
| style="white-space: pre-wrap;" | [[ | | style="text-align:center; white-space: pre-wrap;" | [[Reasons given for samples being too small according to power analysis::{{{Reasons given for samples being too small according to power analysis|}}}]] | ||
|- | |||
! style="text-align:left;" | If no power analysis performed: at least moderate sample size (n >= 30 per arm) | |||
| style="text-align:center;" | [[Samples sufficiently large::{{{Samples sufficiently large|}}}]] | |||
|- | |- | ||
! style="text-align:left;" | Ethnicity mentioned | ! style="text-align:left;" | Ethnicity mentioned | ||
| [[Ethnicity mentioned::{{{Ethnicity mentioned|}}}]] | | style="text-align:center;" | [[Ethnicity mentioned::{{{Ethnicity mentioned|}}}]] | ||
|} | |} | ||
== | ==Alternative Explanation== | ||
{| class="wikitable" style="width:75%;" | {| class="wikitable" style="width:75%;" | ||
|- | |- | ||
! width= | ! width=50% style="text-align:left;" | Other explanations for an effect besides the investigated intervention | ||
| [[Possibility of attention effects::{{{Possibility of attention effects|}}}]] | | style="text-align:center;" | [[Other explanations for an effect besides the investigated intervention::{{{Other explanations for an effect besides the investigated intervention|}}}]] | ||
|- | |||
! style="text-align:left; text-indent:3em;" | - Possibility of attention effects | |||
| style="white-space: pre-wrap;" | [[Possibility of attention effects::{{{Possibility of attention effects|}}}]] | |||
|- | |- | ||
! style="text-align:left;" | Possibility of placebo effects | ! style="text-align:left; text-indent:3em;" | - Possibility of placebo effects | ||
| [[Possibility of placebo effects::{{{Possibility of placebo effects|}}}]] | | style="white-space: pre-wrap;" | [[Possibility of placebo effects::{{{Possibility of placebo effects|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | Other reasons | ! style="text-align:left; text-indent:3em;" | - Other reasons | ||
| style="white-space: pre-wrap;" | [[Other reasons::{{{Other reasons|}}}]] | | style="white-space: pre-wrap;" | [[Other reasons::{{{Other reasons|}}}]] | ||
|} | |} | ||
Line 30: | Line 38: | ||
{| class="wikitable" style="width:75%;" | {| class="wikitable" style="width:75%;" | ||
|- | |- | ||
! width= | ! width=75% style="text-align:left;" | Correct use of parametric and non-parametric tests | ||
| style="text-align:center;" | [[Correct use of parametric and non-parametric tests::{{{Correct use of parametric and non-parametric tests|}}}]] | |||
| | |||
| [[Correct | |||
|- | |- | ||
! style="text-align:left;" | Correction for multiple testing | ! style="text-align:left;" | Correction for multiple testing | ||
| [[Correction for multiple testing::{{{Correction for multiple testing|}}}]] | | style="text-align:center;" | [[Correction for multiple testing::{{{Correction for multiple testing|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | Measurement of compliance | ! style="text-align:left;" | Measurement of compliance | ||
| [[Measurement of compliance::{{{Measurement of compliance|}}}]] | | style="text-align:center;" | [[Measurement of compliance::{{{Measurement of compliance|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | Blinding reliable | ! style="text-align:left;" | Blinding reliable | ||
| [[Blinding reliable::{{{Blinding reliable|}}}]] | | style="text-align:center;" | [[Blinding reliable::{{{Blinding reliable|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | Check whether blinding was successful | ! style="text-align:left;" | Check whether blinding (of participants) was successful | ||
| [[Check whether blinding was successful::{{{Check whether blinding was successful|}}}]] | | style="text-align:center;" | [[Check whether blinding was successful::{{{Check whether blinding was successful|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | Consistent reporting in numbers | ! style="text-align:left;" | Consistent reporting in numbers (figures, flowchart, abstract, results) | ||
| [[Consistent reporting in numbers::{{{Consistent reporting in numbers|}}}]] | | style="text-align:center;" | [[Consistent reporting in numbers::{{{Consistent reporting in numbers|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | | ! style="text-align:left;" | Comprehensive and coherent reporting | ||
| [[ | | style="text-align:center;" | [[Comprehensive and coherent reporting::{{{Comprehensive and coherent reporting|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | | ! style="text-align:left;" | Cross-over | ||
| [[ | | style="text-align:center;" | [[Cross-over::{{{Cross-over|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | | ! style="text-align:left; text-indent:3em;" | - Sufficient washout period | ||
| [[ | | style="text-align:center;" | [[sufficient washout period::{{{sufficient washout period|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | | ! style="text-align:left; text-indent:3em;" | - Tested for carry-over effects | ||
| [[ | | style="text-align:center;" | [[Tested for carry-over effects::{{{Tested for carry-over effects|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | | ! style="text-align:left; text-indent:3em;" | - Tested for sequence effects | ||
| [[Were | | style="text-align:center;" | [[Were sequence effects tested::{{{Were sequence effects tested|}}}]] | ||
|} | |} | ||
==Interpretation of results== | ==Interpretation of results== | ||
{| class="wikitable" style="width:75%;" | {| class="wikitable" style="width:75%;" | ||
|- | |- | ||
! width= | ! width=75% style="text-align:left;" | Effect sizes reported (clinical vs. statistical significance) | ||
| [[Effect sizes reported::{{{Effect sizes reported|}}}]] | | style="text-align:center;" | [[Effect sizes reported::{{{Effect sizes reported|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | Side effects | ! style="text-align:left;" | Side effects systematically recorded | ||
| [[ | | style="text-align:center;" | [[Were side effects systematically recorded::{{{Were side effects systematically recorded|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | | ! style="text-align:left;" | Side effects considered in result interpretation | ||
| [[ | | style="text-align:center;" | [[Side effects taken into account in the interpretation of the results::{{{Side effects taken into account in the interpretation of the results|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | Ethics | ! style="text-align:left;" | Ethics votum | ||
| style=" | | style="text-align:center;" | [[Ethics / CoI / Funding::{{{Ethics / CoI / Funding|}}}]] | ||
|} | |} | ||
</includeonly> | </includeonly> |
Revision as of 11:50, 21 August 2024
This is the "Further points for assessing the study" template.
It should be called in the following format:
{{Further points for assessing the study |Samples sufficiently large= |power analysis performed= |reasons given for samples= |Ethnicity mentioned= |Possibility of attention effects= |Possibility of placebo effects= |Other reasons= |Testing for normal distribution= |Correct application of statistical= |Correction for multiple testing= |Measurement of compliance= |Blinding reliable= |Check whether blinding was successful= |Consistent reporting in numbers= |Sufficient washout period= |Tested for carry-over= |Were sequence effects tested= |Comprehensive and coherent reporting= |Were side effects systematically recorded= |Effect sizes reported= |Side effects taken into account in the interpretation of the results= |mono- or multicentric= |Ethics / CoI / Funding= }}
Edit the page to see the template text.